However, there are no studies related to the reversal of ESCC radioresistance by everolimus or temsirolimus, which provides a direction for future studies on targeted mTOR inhibitors against ESCC radioresistance. This evidence concerns the gene MTOR and esophageal squamous cell carcinoma.